Study to Demonstrate the Non-inferiority of Olmesartan Medoxomil Versus Candesartan Cilexetil in Reducing Blood B-type (or Brain) Natriuretic Peptide Levels at Week 24

Clinical trial NCT00679484 · TERMINATED

Trial details

NCT number: NCT00679484
Sponsor: Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Chronic Heart Failure High Blood B-type (or Brain) Natriuretic Peptide (BNP) Level

Start date: 2008-06-01
Primary completion: 2009-11-01
Enrollment: 400

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.